Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Cardiomyopathies/complications/therapy; Female; Humans; Male; Middle Aged; Mitral Valve Insufficiency/complications; Pacemaker, Artificial; Sensitivity and Specificity; Severity of Illness Index; Ventricular Remodeling
Abstract :
[en] This study investigated the impact of ischemic mitral regurgitation (MR) severity and viability on left ventricular (LV) reverse remodeling after cardiac resynchronization therapy (CRT) in patients with ischemic cardiomyopathy. Severe MR and ischemic cardiomyopathy have been associated with lack of LV reverse remodeling after CRT. Fifty-seven consecutive patients with ischemic MR, LV ejection fraction < or =35%, QRS duration > or =120 ms, and intraventricular dyssynchrony > or =50 ms were prospectively included. Stress echocardiography was performed before CRT implantation. Viability in the region of the LV pacing lead was defined as the presence of viability in 2 contiguous segments. Response to CRT at 6 months was defined by evidence of > or =15% LV decrease in end-systolic volume. Severe MR was defined by an effective regurgitant orifice (ERO) area > or =20 mm(2). Thirty-three patients (58%) were responders at follow-up. Baseline ERO area and prevalence of severe MR were not different between responders and nonresponders (19 +/- 11 vs 21 +/- 13 mm(2), p = 0.67; 52% vs 53%, p = 0.84). In responders, MR was decreased by 58% (ERO 19 +/- 12 to 8 +/- 6 mm(2)). In the presence of viability in the region of the pacing lead, 74% (n = 29 patients) were responders (sensitivity 88%, specificity 58%); in the subgroup of patients with viability in the region of the pacing lead and severe MR, 83% (n = 17 patients) were responders. In conclusion, LV remodeling is frequent and ischemic MR decrease important in patients with viability in the region of the pacing lead without regard to MR severity.
Disciplines :
General & internal medicine Cardiovascular & respiratory systems
Author, co-author :
Senechal, Mario; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada > Département de cardiologie
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Imagerie cardiaque fonctionnelle par échographie
Magne, Julien ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Garceau, Patrick; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada > Département de cardiologie
Champagne, Jean; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada > Département de cardiologie
Philippon, Francois; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada > Département de cardiologie
O'Hara, Gilles; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada > Département de cardiologie
Moonen, Marie ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Dubois, Michelle; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada > Département de cardiologie
Language :
English
Title :
Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
Publication date :
01 July 2010
Journal title :
American Journal of Cardiology
ISSN :
0002-9149
eISSN :
1879-1913
Publisher :
Elsevier Science, New York, United States - New York
Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., Garrigue S., Kappenberger L., Haywood G.A., Santini M., Bailleul C., and Daubert J.C. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., Ellestad M., Tupp R.J., Underwood J., Pickering F., Truex C., McAtee P., Messenger J., and MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., and Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
Tournoux F.B., Alabiad C., Fan D., Chen A.A., Chaput M., Heist E.K., Mela T., Mansour M., Reddy V., Ruskin J.N., Picard M.H., and Singh J.P. Echocardiographic measure of acute haemodynamic response after cardiac resynchronization therapy predicts long term clinical outcome. Eur Heart J 28 (2007) 1143-1148
Gorcsan III J., Kanzaki H., Bazaz R., Dohi K., and Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol 93 (2004) 1178-1181
Breithardt O.A., Sinha A.M., Schwammenthal E., Bidaoui N., Markus K.U., Franke A., and Stellbrink C. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
Kanzaki H., Bazaz R., Schwartzman D., Dohi K., Sade L.E., and Gorcsan III J. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1619-1625
Vinereanu D., Turner M.S., Bleasdale R.A., Mumford C.E., Cinteza M., Frenneaux M.P., and Fraser A.G. Mechanisms of reduction of mitral regurgitation by cardiac resynchronization therapy. J Am Soc Echocardiogr 20 (2007) 54-62
Karvounis H.I., Dalamaga E.G., Papadopoulos C.E., Karamitsos T.D., Vassilikos V., Paraskevaidis S., Styliadis I.H., Parharidis G.E., and Louridas G.E. Improved papillary muscle function attenuates functional mitral regurgitation in patients with dilated cardiomyopathy after cardiac resynchronization therapy. J Am Soc Echocardiogr 19 (2006) 1150-1157
Agricola E., Oppizzi M., Galderisi M., Pisani M., Meris A., Pappone C., and Magonato A. Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Heart 92 (2006) 1390-1395
Madaric J., Vanderheyden M., Van Laethem C., Verhamme K., Feys A., Goethals M., Verstreken S., Geelen P., Penicka M., De Bruyne B., and Bartek J. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodeling and cardiopulmonary performance. Eur Heart J 28 (2007) 2134-2141
Diaz-Infante E., Mont L., Leal J., García-Bolao I., Fernández-Lozano I., Hernández-Madrid A., Pérez-Castellano N., Sitges M., Pavón-Jiménez R., Barba J., Cavero M.A., Moya J.L., Pérez-Isla L., and Brugada J. Predictors of lack of response to resynchronization therapy. Am J Cardiol 95 (2005) 1436-1440
Vinereanu D. Mitral regurgitation and cardiac resynchronization therapy. Echocardiography 25 (2008) 1155-1166
Cabrera-Bueno F., García-Pinilla J.M., Peña-Hernández J., Jiménez-Navarro M., Gómez-Doblas J.J., Barrera-Cordero A., Alzueta-Rodriguez J., and de Teresa-Galván E. Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy. Europace 9 (2007) 757-761
Sutton M.G., Plappert T., Hilpisch K.E., Abraham W.T., Hayes D.L., and Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSyc Randomized Clinical Evaluation (MIRACLE). Circulation 113 (2006) 266-272
Zoghbi W.A., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Levine R.A., Nihoyannopoulos P., Otto C.M., Quinones M.A., Rakowski H., Stewart W.J., Waggoner A., and Weissman N.J. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
Bader H., Garrigue S., Lafitte S., Reuter S., Jaïs P., Haïssaguerre M., Bonnet J., Clementy J., and Roudaut R. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 43 (2004) 248-256
Ciampi Q., Pratali L., Citro R., Piacenti M., Villari B., and Picano E. Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography. Eur J Heart Fail 11 (2009) 489-496
Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., Silverman N.H., and Tajik A.J. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
Butter C., Auricchio A., Stellbrink C., Fleck E., Ding J., Yu Y., Huvelle E., and Spinelli J. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 104 (2001) 3026-3029
Molhoek S.G., Bax J.J., van Erven L., Bootsma M., Boersma E., Steendijk P., van der Wall E.E., and Schalij M.J. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 860-863
Vidal B., Sitges M., Delgado V., Mont L., Díaz-Infante E., Azqueta M., Paré C., Tolosana J.M., Berruezo A., Tamborero D., Roig E., and Brugada J. Influence of cardiopathy etiology on responses to cardiac resynchronisation therapy. Rev Esp Cardiol 60 (2007) 1264-1271
Mangiavacchi M., Gasparini M., Faletra F., Klersy C., Morenghi E., Galimberti P., Genovese L., Regoli F., De Chiara F., Bragato R., Andreuzzi B., Pini D., and Gronda E. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. Am Heart J 151 suppl (2006) 477.e1-477.e6
Bleeker G.B., Mollema S.A., Holman E.R., Van de Veire N., Ypenburg C., Boersma E., van der Wall E.E., Schalij M.J., and Bax J.J. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 116 (2007) 1440-1448
Yu C.M., Bleeker G.B., Fung J.W., Schalij M.J., Zhang Q., van der Wall E.E., Chan Y.S., Konbg S.L., and Bax J.J. Left ventricular reverse remodeling but not clinical improvement predict long-term survival after cardiac resynchronization therapy. Circulation 112 (2005) 1580-1586
Cleland J., Freemantle N., Ghio S., Fruhwald F., Shankar A., Marijanowski M., Verboven Y., and Tavazzi L. Predicting the long-term of cardiac resynchronization therapy on mortality from baseline variables and the early response. A report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. J Am Coll Cardiol 52 (2008) 438-445
Bleeker G.B., Kaandorp T.A.M., Lamb J.H., Boersma E., Steendijk P., de Roos A., van der Wall E.E., Schalij M.J., and Bax J.J. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113 (2006) 969-976
Lim P., Bars C., Mitchell-Hegg L., Roiron C., Elbaz N., Hamdaoui B., Lellouche N., Dubois-Randé J.L., and Guéret P. Importance of contractile reserve for CRT. Europace 9 (2007) 739-743
Sénéchal M., Lancellotti P., Garceau P., Champagne J., Dubois M., Magne J., Blier L., Molin F., Philippon F., Dumesnil J.G., Pierard L., and O'Hara G. Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy. Echocardiography 27 (2010) 50-57
Lancelloti P., Sénéchal M., Moonen M., Donal E., Magne J., Nellessen E., Attena E., Cosyns B., Melon P., and Piérard L. Myocardial contractile reserve during exercise predicts left ventricular reverse remodeling after cardiac resynchronization therapy. Eur J Echocardiogr 10 (2009) 663-668
